PDGFRA: Comprehensive Cross-Database Identifier and Functional Mapping Reference
╔══════════════════════════════════════════════════════════════════════════════╗
║ PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) ║
║ Human Gene Reference Document ║
╚══════════════════════════════════════════════════════════════════════════════╝
Section 1: Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC ID | HGNC:8803 | Approved symbol: PDGFRA |
| HGNC Name | platelet derived growth factor receptor alpha | |
| Ensembl Gene | ENSG00000134853 | |
| NCBI Entrez | 5156 | |
| OMIM | 173490 | Gene/locus |
| CCDS | CCDS3495 | Consensus CDS |
| PharmGKB | PA33147 | VIP gene |
Genomic Location (GRCh38/hg38)
| Attribute | Value |
|---|
| Chromosome | 4 |
| Cytogenetic Band | 4q12 |
| Start Position | 54,229,130 |
| End Position | 54,298,246 |
| Strand | + (forward) |
| Genomic Accession | NC_000004.12 |
| Gene Span | ~69.1 kb |
Gene Aliases
CD140a, CD140A
PDGFR2, PDGFR-2
GAS9
Gene Classification
Locus Type: gene with protein product
Locus Group: protein-coding gene
Gene Groups: Receptor tyrosine kinases, CD molecules, I-set domain containing
Section 2: Transcript Identifiers
Ensembl Transcripts
Total transcript count: 23
| Transcript ID | Biotype | Start | End | Strand |
|---|
| ENST00000257290 | protein_coding | 54,229,293 | 54,298,245 | + |
| ENST00000958745 | protein_coding | 54,229,132 | 54,298,243 | + |
| ENST00000958746 | protein_coding | 54,229,147 | 54,298,244 | + |
| ENST00000958747 | protein_coding | 54,229,249 | 54,298,243 | + |
| ENST00000958748 | protein_coding | 54,229,281 | 54,298,242 | + |
| ENST00000958749 | protein_coding | 54,229,303 | 54,298,246 | + |
| ENST00000958750 | protein_coding | 54,229,823 | 54,298,245 | + |
| ENST00000958751 | protein_coding | 54,229,881 | 54,298,244 | + |
| ENST00000958752 | protein_coding | 54,230,014 | 54,298,242 | + |
| ENST00000958753 | protein_coding | 54,229,130 | 54,297,345 | + |
| ENST00000958754 | protein_coding | 54,232,722 | 54,298,244 | + |
| ENST00000958755 | protein_coding | 54,233,102 | 54,298,246 | + |
| ENST00000870889 | protein_coding | 54,231,979 | 54,298,245 | + |
| ENST00000870890 | protein_coding | 54,233,071 | 54,298,244 | + |
| ENST00000508170 | protein_coding | 54,229,280 | 54,265,353 | + |
| ENST00000503856 | protein_coding | 54,229,843 | 54,263,776 | + |
| ENST00000504461 | protein_coding | 54,230,322 | 54,263,773 | + |
| ENST00000512143 | protein_coding | 54,229,293 | 54,261,412 | + |
| ENST00000512522 | protein_coding | 54,243,575 | 54,263,762 | + |
| ENST00000509490 | nonsense_mediated_decay | 54,229,311 | 54,281,978 | + |
| ENST00000461294 | retained_intron | 54,276,751 | 54,278,246 | + |
| ENST00000507536 | retained_intron | 54,277,176 | 54,281,977 | + |
| ENST00000509092 | retained_intron | 54,229,292 | 54,280,758 | + |
RefSeq Transcripts (Human, Reviewed)
| Accession | Type | MANE Select | Chromosome |
|---|
| NM_006206 | mRNA | ✓ YES | 4 |
| NM_001347827 | mRNA | | 4 |
| NM_001347828 | mRNA | | 4 |
| NM_001347829 | mRNA | | 4 |
| NM_001347830 | mRNA | | 4 |
CCDS Identifiers
Exons for Canonical Transcript (ENST00000257290)
Total exon count: 23
| Exon ID | Start | End | Length |
|---|
| ENSE00002028061 | 54,229,293 | 54,229,415 | 123 bp |
| ENSE00003785223 | 54,261,095 | 54,261,412 | 318 bp |
| ENSE00003634368 | 54,263,667 | 54,263,927 | 261 bp |
| ENSE00003580939 | 54,264,919 | 54,265,049 | 131 bp |
| ENSE00003566972 | 54,267,289 | 54,267,460 | 172 bp |
| ENSE00003547009 | 54,267,552 | 54,267,741 | 190 bp |
| ENSE00003674470 | 54,270,633 | 54,270,748 | 116 bp |
| ENSE00003626526 | 54,272,394 | 54,272,520 | 127 bp |
| ENSE00003584929 | 54,273,537 | 54,273,730 | 194 bp |
| ENSE00003548932 | 54,274,531 | 54,274,625 | 95 bp |
| ENSE00003571737 | 54,274,841 | 54,274,973 | 133 bp |
| ENSE00003673604 | 54,277,388 | 54,277,492 | 105 bp |
| ENSE00003529069 | 54,277,896 | 54,278,006 | 111 bp |
| ENSE00003464046 | 54,278,362 | 54,278,515 | 154 bp |
| ENSE00003647873 | 54,280,316 | 54,280,482 | 167 bp |
| ENSE00003483772 | 54,285,371 | 54,285,486 | 116 bp |
| ENSE00003570052 | 54,285,841 | 54,285,963 | 123 bp |
| ENSE00003681641 | 54,287,430 | 54,287,541 | 112 bp |
| ENSE00003586981 | 54,288,799 | 54,288,898 | 100 bp |
| ENSE00003462897 | 54,289,009 | 54,289,114 | 106 bp |
| ENSE00003471835 | 54,290,313 | 54,290,554 | 242 bp |
| ENSE00003482129 | 54,258,757 | 54,258,817 | 61 bp |
| ENSE00001226318 | 54,295,125 | 54,298,245 | 3,121 bp |
Section 3: Protein Identifiers
UniProt Accessions
| Accession | Status | Name |
|---|
| P16234 | ✓ Reviewed (Swiss-Prot) | Platelet-derived growth factor receptor alpha |
Protein Properties
| Property | Value |
|---|
| Length | 1,089 amino acids |
| Mass | 122,670 Da |
| Alternative Names | Alpha platelet-derived growth factor receptor, Alpha-type PDGF receptor, CD140a antigen, PDGFR-2 |
RefSeq Protein Accessions (Human)
| Accession | MANE Select | Status |
|---|
| NP_006197 | ✓ YES | Reviewed |
| NP_001334756 | | Reviewed |
| NP_001334757 | | Reviewed |
| NP_001334758 | | Reviewed |
| NP_001334759 | | Reviewed |
Protein Domains and Families (InterPro)
Total domain annotations: 15
| InterPro ID | Name | Type |
|---|
| IPR027290 | PDGFRA | Family |
| IPR050122 | RTK | Family |
| IPR000719 | Prot_kinase_dom | Domain |
| IPR001245 | Ser-Thr/Tyr_kinase_cat_dom | Domain |
| IPR020635 | Tyr_kinase_cat_dom | Domain |
| IPR003598 | Ig_sub2 | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013098 | Ig_I-set | Domain |
| IPR011009 | Kinase-like_dom_sf | Homologous_superfamily |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR001824 | Tyr_kinase_rcpt_3_CS | Conserved_site |
| IPR008266 | Tyr_kinase_AS | Active_site |
| IPR017441 | Protein_kinase_ATP_BS | Binding_site |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total PDB structure count: 15
| PDB ID | Method | Resolution | Title |
|---|
| 5GRN | X-ray | 1.77 Å | PDGFRA in Complex with WQ-C-159 |
| 8PQJ | X-ray | 1.82 Å | PDGFRA wild-type kinase domain |
| 6A32 | X-ray | 1.87 Å | PDGFRA kinase domain mutant T674I |
| 6JOL | X-ray | 1.9 Å | PDGFRA in complex with imatinib |
| 8PQK | X-ray | 2.0 Å | APO PDGFRA-T674I kinase domain |
| 5K5X | X-ray | 2.17 Å | Crystal structure of human PDGFRA |
| 1GQ5 | X-ray | 2.2 Å | NHERF Interaction with PDGFR |
| 9GZH | X-ray | 2.2 Å | PDGFRA-T674I with covalent ponatinib derivative |
| 8PQH | X-ray | 2.5 Å | PDGFRA T674I with avapritinib |
| 8PQI | X-ray | 2.6 Å | PDGFRA T674I with avapritinib derivative 9 |
| 6JOJ | X-ray | 2.6 Å | PDGFRA T674I with crenolanib (soaking) |
| 7LBF | Cryo-EM | 2.8 Å | HCMV Trimer gHgLgO with PDGFRα |
| 6JOI | X-ray | 3.1 Å | PDGFRA T674I with crenolanib (co-cryst) |
| 7RAM | Cryo-EM | 3.43 Å | HCMV gHgLgO Trimer with PDGFRα |
| 6JOK | X-ray | 3.8 Å | PDGFRA with sunitinib (soaking) |
Predicted Structures (AlphaFold)
| AlphaFold ID | Sequence Length | Global pLDDT | Fraction Very High Confidence |
|---|
| P16234 | 8,623 | 72.91 | 0.25 (25%) |
Section 5: Cross-Species Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000029231 | Pdgfra | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000002244 | Pdgfra | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000070494 | pdgfra | protein_coding |
| Fruit fly (D. melanogaster) | No direct ortholog | — | — |
| Worm (C. elegans) | No direct ortholog | — | — |
| Yeast (S. cerevisiae) | No direct ortholog | — | — |
Note: Paralogs in human genome: 53 identified
Section 6: Clinical Variants & AI Predictions
ClinVar Variant Summary
Total variants in ClinVar: 3,760
| Classification | Count |
|---|
| Pathogenic | 6 |
| Likely Pathogenic | 1 |
| Uncertain Significance (VUS) | ~3,400+ |
| Likely Benign | 200+ |
| Benign | 92 |
| Conflicting | 4 |
Pathogenic Variants (All 6)
| ClinVar ID | HGVS Notation | Type | Associated Condition |
|---|
| 13545 | c.2533_2544del (p.His845_Asn848del) | Deletion | GIST |
| 13547 | c.1681_1682insAGAGGG (p.Arg560_Val561insGluArg) | Insertion | GIST |
| 13548 | c.1679_1693del (p.Arg560_Ser564del) | Deletion | GIST |
| 13549 | c.1696_1713del (p.Ser566_Glu571del) | Deletion | GIST |
| 635777 | c.1957_1958delinsTT (p.Pro653Leu) | Indel | GIST |
| 635778 | c.2537A>T (p.Asp846Val) | SNV | GIST |
Likely Pathogenic Variants (1)
| ClinVar ID | HGVS Notation | Type |
|---|
| 13552 | c.1664A>G (p.Tyr555Cys) | SNV |
AI-Based Splice Effect Predictions (SpliceAI)
Total splice-affecting variants predicted: 4,137
TOP 50 High-Confidence Splice-Altering Variants (score ≥0.5):
| Variant | Gene | Effect | Delta Score |
|---|
| 4:54229148:G:GT | PDGFRA | donor_gain | 0.96 |
| 4:54229412:GAAG:G | PDGFRA | donor_gain | 0.98 |
| 4:54229414:AGG:A | PDGFRA | donor_loss | 0.98 |
| 4:54229416:G:GA | PDGFRA | donor_loss | 0.98 |
| 4:54229416:G:GG | PDGFRA | donor_gain | 0.96 |
| 4:54229417:T:G | PDGFRA | donor_loss | 0.98 |
| 4:54229553:GAGA:G | PDGFRA | donor_gain | 0.81 |
| 4:54229554:A:T | PDGFRA | donor_gain | 0.79 |
| 4:54229555:GA:G | PDGFRA | donor_gain | 0.75 |
| 4:54229185:GT:G | PDGFRA | donor_gain | 0.73 |
| 4:54229186:T:TA | PDGFRA | donor_gain | 0.76 |
| 4:54229149:GAGTT:G | PDGFRA | donor_gain | 0.67 |
| 4:54229301:TGGAG:T | PDGFRA | acceptor_gain | 0.66 |
| 4:54229287:G:GC | PDGFRA | acceptor_gain | 0.64 |
| 4:54230080:T:G | PDGFRA | donor_gain | 0.61 |
| 4:54229273:A:AG | PDGFRA | acceptor_gain | 0.60 |
| 4:54229302:GGAG:G | PDGFRA | acceptor_gain | 0.60 |
| 4:54229305:G:T | PDGFRA | acceptor_gain | 0.60 |
| 4:54229274:A:G | PDGFRA | acceptor_gain | 0.57 |
| 4:54229149:G:T | PDGFRA | donor_gain | 0.55 |
| 4:54229418:A:C | PDGFRA | donor_loss | 0.54 |
| 4:54229422:G:T | PDGFRA | donor_gain | 0.54 |
| 4:54229541:GTT:G | PDGFRA | donor_gain | 0.53 |
| 4:54230058:G:GT | PDGFRA | donor_gain | 0.52 |
| 4:54229414:AG:A | PDGFRA | donor_gain | 0.50 |
| 4:54229415:GG:G | PDGFRA | donor_gain | 0.50 |
| 4:54229910:TGTG:T | PDGFRA | donor_gain | 0.50 |
| 4:54229911:GTGG:G | PDGFRA | donor_gain | 0.50 |
| 4:54229912:T:A | PDGFRA | donor_gain | 0.50 |
| ... | ... | ... | ... |
AI-Based Missense Pathogenicity Predictions (AlphaMissense)
Total missense predictions: 7,179
Classification Distribution:
- Likely Pathogenic: ~2,500+
- Ambiguous: ~1,000+
- Likely Benign: ~3,500+
TOP 50 Predicted Pathogenic Missense Variants (am_pathogenicity ≥0.95):
| Variant | Protein Change | AM Score | Class |
|---|
| 4:54261190:T:A | C49S | 0.999 | likely_pathogenic |
| 4:54261190:T:C | C49R | 0.998 | likely_pathogenic |
| 4:54261192:C:G | C49W | 0.998 | likely_pathogenic |
| 4:54261191:G:A | C49Y | 0.997 | likely_pathogenic |
| 4:54261191:G:C | C49S | 0.999 | likely_pathogenic |
| 4:54261191:G:T | C49F | 0.995 | likely_pathogenic |
| 4:54261214:T:A | W57R | 0.999 | likely_pathogenic |
| 4:54261214:T:C | W57R | 0.999 | likely_pathogenic |
| 4:54261216:G:C | W57C | 0.999 | likely_pathogenic |
| 4:54261216:G:T | W57C | 0.999 | likely_pathogenic |
| 4:54261215:G:C | W57S | 0.995 | likely_pathogenic |
| 4:54261185:T:C | L47P | 0.996 | likely_pathogenic |
| 4:54261197:G:A | G51E | 0.983 | likely_pathogenic |
| 4:54261197:G:T | G51V | 0.985 | likely_pathogenic |
| 4:54261196:G:T | G51W | 0.989 | likely_pathogenic |
| 4:54261190:T:G | C49G | 0.987 | likely_pathogenic |
| 4:54261214:T:G | W57G | 0.987 | likely_pathogenic |
| 4:54261179:T:C | F45S | 0.983 | likely_pathogenic |
| 4:54261179:T:G | F45C | 0.981 | likely_pathogenic |
| 4:54261185:T:G | L47R | 0.978 | likely_pathogenic |
| 4:54261196:G:A | G51R | 0.975 | likely_pathogenic |
| 4:54261196:G:C | G51R | 0.975 | likely_pathogenic |
| 4:54261185:T:A | L47Q | 0.971 | likely_pathogenic |
| 4:54261128:C:A | P28H | 0.969 | likely_pathogenic |
| 4:54261178:T:C | F45L | 0.963 | likely_pathogenic |
| ... | ... | ... | ... |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total pathway count: 13
| Pathway ID | Name | Disease Pathway |
|---|
| R-HSA-186797 | Signaling by PDGF | No |
| R-HSA-186763 | Downstream signal transduction | No |
| R-HSA-1257604 | PIP3 activates AKT signaling | No |
| R-HSA-5673001 | RAF/MAP kinase cascade | No |
| R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | No |
| R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | Yes |
| R-HSA-9673767 | Signaling by PDGFRA transmembrane/juxtamembrane/kinase domain mutants | Yes |
| R-HSA-9673770 | Signaling by PDGFRA extracellular domain mutants | Yes |
| R-HSA-9674396 | Imatinib-resistant PDGFR mutants | Yes |
| R-HSA-9674401 | Sunitinib-resistant PDGFR mutants | Yes |
| R-HSA-9674403 | Regorafenib-resistant PDGFR mutants | Yes |
| R-HSA-9674404 | Sorafenib-resistant PDGFR mutants | Yes |
| R-HSA-9674428 | PDGFR mutants bind TKIs | Yes |
Gene Ontology Annotations
Total GO terms: 70
Molecular Function (14 terms)
| GO ID | Term |
|---|
| GO:0005018 | platelet-derived growth factor alpha-receptor activity |
| GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
| GO:0004672 | protein kinase activity |
| GO:0005524 | ATP binding |
| GO:0048407 | platelet-derived growth factor binding |
| GO:0005161 | platelet-derived growth factor receptor binding |
| GO:0005021 | vascular endothelial growth factor receptor activity |
| GO:0038085 | vascular endothelial growth factor binding |
| GO:0042803 | protein homodimerization activity |
| GO:0044877 | protein-containing complex binding |
| GO:0160185 | phospholipase C activator activity |
| ... | ... |
Biological Process (41 terms)
| GO ID | Term |
|---|
| GO:0048008 | platelet-derived growth factor receptor signaling pathway |
| GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway |
| GO:0038091 | positive regulation of cell proliferation by VEGF-activated PDGFR signaling |
| GO:0007169 | cell surface receptor protein tyrosine kinase signaling pathway |
| GO:0018108 | peptidyl-tyrosine phosphorylation |
| GO:0046777 | protein autophosphorylation |
| GO:0008284 | positive regulation of cell population proliferation |
| GO:0016477 | cell migration |
| GO:0030335 | positive regulation of cell migration |
| GO:0042060 | wound healing |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
| GO:0051897 | positive regulation of PI3K/AKT signaling |
| GO:0001701 | in utero embryonic development |
| GO:0030324 | lung development |
| GO:0060021 | roof of mouth development |
| GO:0048704 | embryonic skeletal system morphogenesis |
| GO:0050872 | white fat cell differentiation |
| GO:0030198 | extracellular matrix organization |
| GO:0032956 | regulation of actin cytoskeleton organization |
| GO:0055003 | cardiac myofibril assembly |
| ... | ... |
Cellular Component (15 terms)
| GO ID | Term |
|---|
| GO:0005886 | plasma membrane |
| GO:0009897 | external side of plasma membrane |
| GO:0016020 | membrane |
| GO:0005789 | endoplasmic reticulum membrane |
| GO:0005794 | Golgi apparatus |
| GO:0005829 | cytosol |
| GO:0005737 | cytoplasm |
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0043235 | receptor complex |
| GO:1990270 | platelet-derived growth factor receptor-ligand complex |
| GO:0032991 | protein-containing complex |
| GO:0005929 | cilium |
| GO:0005902 | microvillus |
| GO:0030054 | cell junction |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interactions (STRING)
Total high-confidence interactions: 4,664+
TOP 50 Highest-Confidence Interactors:
| UniProt ID | Gene | Score | Description |
|---|
| P04085 | PDGFA | 998 | Platelet-derived growth factor A |
| Q9NRA1 | PDGFC | 998 | Platelet-derived growth factor C |
| P01127 | PDGFB | 996 | Platelet-derived growth factor B |
| Q9GZP0 | PDGFD | 991 | Platelet-derived growth factor D |
| Q6UN15 | FIP1L1 | 981 | FIP1-like 1 protein |
| P09038 | FGF2 | 941 | Fibroblast growth factor 2 |
| Q06124 | PTPN11 | 889 | Tyrosine-protein phosphatase SHP-2 |
| P01133 | EGF | 877 | Pro-epidermal growth factor |
| P42336 | PIK3CA | 867 | PI3-kinase p110α catalytic subunit |
| P21583 | SCF/KITLG | 809 | Kit ligand |
| Q13516 | OLIG2 | 809 | Oligodendrocyte TF 2 |
| Q5XXA6 | ANO1 | 804 | Anoctamin-1 |
| P21359 | NF1 | 803 | Neurofibromin |
| P27986 | PIK3R1 | 796 | PI3K regulatory subunit alpha |
| P60484 | PTEN | 796 | Phosphatase and tensin homolog |
| P01116 | KRAS | 783 | GTPase KRas |
| Q99643 | SDHC | 776 | Succinate dehydrogenase C |
| P01137 | TGFB1 | 761 | Transforming growth factor beta-1 |
| Q92913 | PCDHGA10 | 760 | Protocadherin gamma-A10 |
| Q6UVK1 | CSPG4 | 751 | Chondroitin sulfate proteoglycan 4 |
| P48061 | CXCL12 | 749 | Stromal cell-derived factor 1 |
| P21912 | SDHB | 746 | Succinate dehydrogenase B |
| P35222 | CTNNB1 | 745 | Catenin beta-1 |
| P48681 | NES | 739 | Nestin |
| O14521 | SDHD | 735 | Succinate dehydrogenase D |
| P28906 | CD34 | 731 | CD34 antigen |
| O75874 | IDH1 | 727 | Isocitrate dehydrogenase 1 |
| P17813 | ENG | 725 | Endoglin |
| P16284 | PECAM1 | 723 | Platelet endothelial cell adhesion molecule |
| P14136 | GFAP | 722 | Glial fibrillary acidic protein |
| ... | ... | ... | ... |
BioGRID Physical Interactions
Total interactions: 432+
Key Interaction Partners:
- PDGFA, PDGFB, PDGFC (ligands)
- PIK3R1, PIK3CA (PI3K signaling)
- PLCG1 (phospholipase C)
- STAT3 (transcription factor)
- RASA1 (RAS signaling)
- CBL (ubiquitin ligase)
- SRC family kinases
Protein Similarity
ESM2 Structural/Embedding Similarity
Total similar proteins: 151
TOP 20 Most Similar:
| UniProt | Similarity | Description |
|---|
| O08747 | 1.0000 | Mouse Pdgfra |
| O60674 | 1.0000 | JAK2 |
| P43481 | 1.0000 | KDR (VEGFR2) |
| Q00495 | 1.0000 | PDGFRB |
| O97799 | 0.9998 | Bovine PDGFRA |
| P10721 | 0.9998 | KIT |
| P09619 | 0.9996 | PDGFRB |
| P05622 | 0.9999 | CSF1R |
| P35918 | 0.9998 | VEGFR2/KDR |
| P09581 | 1.0000 | PDGFRA (self) |
| Q05030 | 0.9999 | FLT3 |
| P20786 | 0.9999 | FLT4 |
| P35968 | 0.9993 | KDR |
| P00545 | 0.9993 | ABL1 |
| ... | ... | ... |
DIAMOND Sequence Similarity
Total homologous proteins: 98
TOP 20 by Identity:
| UniProt | Identity (%) | Bitscore | Description |
|---|
| P00545 | 99.1 | 1826 | ABL1 |
| Q00495 | 99.6 | 1885 | PDGFRB |
| P09581 | 99.6 | 1887 | PDGFRA (chicken) |
| Q28317 | 99.4 | 1949 | PDGFRA (bovine) |
| P43481 | 99.4 | 1953 | KDR |
| Q4VSN5 | 99.5 | 1807 | PDGFRA (chimp) |
| O97799 | 98.4 | 1845 | PDGFRA (bovine) |
| P10721 | 97.8 | 1840 | KIT |
| P21802 | 97.0 | 1615 | FGFR2 |
| P21803 | 97.0 | 1611 | FGFR3 |
| P05622 | 96.6 | 2091 | CSF1R |
| Q05030 | 96.6 | 2091 | FLT3 |
| P20786 | 96.0 | 2051 | FLT4 |
| P26618 | 96.0 | 2050 | FLT1 |
| ... | ... | ... | ... |
Section 9: Transcription Factor Regulatory Data
Note: PDGFRA is NOT a transcription factor. This section lists TFs that regulate PDGFRA expression.
Upstream Regulators (TFs that regulate PDGFRA)
Total regulatory interactions: 26
| TF Gene | Regulation Type | Confidence |
|---|
| ATF4 | Activation | High |
| E2F1 | Activation | High |
| GATA6 | Activation | High |
| GLI1 | Activation | High |
| GLI2 | Activation | — |
| ASCL1 | Activation | Low |
| HOXC6 | Activation | — |
| MIXL1 | Activation | — |
| CREB1 | Repression | High |
| FOXO1 | Repression | Low |
| PAX3 | Repression | High |
| POU5F1 | Repression | High |
| PPARG | Repression | — |
| SP1 | Unknown | High |
| SP3 | Unknown | High |
| YY1 | Unknown | High |
| FOS | Unknown | High |
| CEBPB | Unknown | — |
| CEBPD | Unknown | High |
| CEBPG | Unknown | High |
| NFKB | Unknown | High |
| PAX1 | Unknown | High |
| SOX10 | Unknown | — |
| GATA4 | Unknown | — |
| ZNF148 | Unknown | High |
| ZNF354C | Unknown | High |
DNA Binding Profiles
- PDGFRA does not encode a transcription factor; therefore, no DNA binding motifs apply.
Section 10: Drug & Pharmacology Data
ChEMBL Target Information
| Target ID | Name | Type |
|---|
| CHEMBL2007 | Platelet-derived growth factor receptor alpha | SINGLE PROTEIN |
| CHEMBL2095189 | Platelet-derived growth factor receptor | PROTEIN COMPLEX |
| CHEMBL4630733 | Cereblon/PDGFRA | PROTEIN-PROTEIN INTERACTION |
Targeting Molecules
Total molecules targeting PDGFRA: 1,394+ (ChEMBL activities)
Phase 4 (Approved) Drugs (24):
| ChEMBL ID | Drug Name | Type |
|---|
| CHEMBL941 | Imatinib | Small molecule |
| CHEMBL1642 | Imatinib mesylate | Small molecule |
| CHEMBL535 | Sunitinib | Small molecule |
| CHEMBL1336 | Sorafenib | Small molecule |
| CHEMBL1946170 | Regorafenib | Small molecule |
| CHEMBL24828 | Vandetanib | Small molecule |
| CHEMBL255863 | Nilotinib | Small molecule |
| CHEMBL288441 | Bosutinib | Small molecule |
| CHEMBL477772 | Pazopanib | Small molecule |
| CHEMBL1289926 | Axitinib | Small molecule |
| CHEMBL1289601 | Lenvatinib | Small molecule |
| CHEMBL1289494 | Tivozanib | Small molecule |
| CHEMBL502835 | Nintedanib | Small molecule |
| CHEMBL3039504 | Nintedanib esylate | Small molecule |
| CHEMBL5416410 | Dasatinib | Small molecule |
| CHEMBL1171837 | Ponatinib | Small molecule |
| CHEMBL2403108 | Ceritinib | Small molecule |
| CHEMBL3813873 | Pexidartinib | Small molecule |
| CHEMBL4204794 | Avapritinib | Small molecule |
| CHEMBL4216467 | Ripretinib | Small molecule |
| CHEMBL608533 | Midostaurin | Small molecule |
| CHEMBL576982 | Quizartinib | Small molecule |
| CHEMBL1287853 | Fedratinib | Small molecule |
| CHEMBL553 | Erlotinib | Small molecule |
Phase 3 Drugs (21):
| ChEMBL ID | Drug Name |
|---|
| CHEMBL101253 | Vatalanib |
| CHEMBL1908391 | Masitinib |
| CHEMBL2105728 | Crenolanib |
| CHEMBL217092 | Saracatinib |
| CHEMBL223360 | Linifanib |
| CHEMBL2316582 | Olverembatinib |
| CHEMBL276711 | Semaxanib |
| CHEMBL31965 | Canertinib |
| CHEMBL377300 | Brivanib |
| CHEMBL377559 | Retaspimycin HCl |
| CHEMBL415049 | Barasertib |
| CHEMBL428690 | Alvocidib |
| CHEMBL491473 | Cediranib |
| CHEMBL5095033 | Ibcasertib |
| CHEMBL5095202 | Vimseltinib |
| CHEMBL522892 | Dovitinib |
| CHEMBL5314535 | Pimicotinib |
| CHEMBL572881 | Motesanib |
| CHEMBL603469 | Lestaurtinib |
| CHEMBL1852688 | Infigratinib |
| CHEMBL1834657 | Infigratinib phosphate |
PharmGKB Drug-Gene Interactions
VIP Gene Status: Yes
| Drug | Clinical Annotations | Variant Annotations | Pathways |
|---|
| Imatinib | 39 | 212 | 1 |
| Sunitinib | 16 | 138 | 2 |
| Avapritinib | 0 | 0 | 0 |
| Olaratumab | 0 | 0 | 0 |
| Mepolizumab | 0 | 2 | 0 |
Clinical Guidelines
- No CPIC guidelines currently available for PDGFRA
Section 11: Expression Profiles
Tissue Expression (Bgee)
Expression breadth: Ubiquitous
Total tissues with expression: 289
Maximum expression score: 99.38
TOP 30 Tissues by Expression Score:
| Tissue | Score | Quality | Rank |
|---|
| Tibia | 99.38 | Gold | 292 |
| Decidua | 99.29 | Gold | 331 |
| Synovial joint | 99.19 | Gold | 379 |
| Pericardium | 99.04 | Gold | 446 |
| Lower lobe of lung | 98.85 | Gold | 538 |
| Pylorus | 98.75 | Gold | 584 |
| Stromal cell of endometrium | 98.74 | Gold | 590 |
| Parietal pleura | 98.67 | Gold | 622 |
| Caput epididymis | 98.58 | Gold | 663 |
| Left ovary | 98.56 | Gold | 672 |
| Pleura | 98.43 | Gold | 732 |
| Cauda epididymis | 98.42 | Gold | 739 |
| Right ovary | 98.29 | Gold | 799 |
| Layer of synovial tissue | 98.11 | Gold | 883 |
| Visceral pleura | 98.06 | Gold | 904 |
| Germinal epithelium of ovary | 97.97 | Gold | 946 |
| Urethra | 97.96 | Gold | 953 |
| Ovary | 97.96 | Gold | 952 |
| Mucosa of urinary bladder | 97.96 | Gold | 954 |
| Mammary duct | 97.90 | Gold | 979 |
| Skin of hip | 97.84 | Gold | 1010 |
| Superficial temporal artery | 97.82 | Gold | 1020 |
| Calcaneal tendon | 97.81 | Gold | 1020 |
| Tendon of biceps brachii | 97.78 | Gold | 1040 |
| Epithelium of mammary gland | 97.69 | Gold | 1080 |
| Heart right ventricle | 97.56 | Gold | 1140 |
| Cardia of stomach | 97.54 | Gold | 1150 |
| Corpus epididymis | 97.47 | Gold | 1180 |
| Jejunal mucosa | 97.30 | Gold | 1260 |
| Tendon | 97.28 | Gold | 1270 |
Single-Cell Expression Data
Total single-cell datasets: 21
| Experiment ID | Description | Species | Cell Count |
|---|
| E-HCAD-35 | Multiple sclerosis neuronal vulnerability | H. sapiens | 477,586 |
| E-MTAB-10287 | Endometrial tissue single-cell | H. sapiens | 340,047 |
| E-MTAB-9543 | Human gastrointestinal tract | H. sapiens | 319,479 |
| E-MTAB-8410 | Colorectal tumors and colon tissue | H. sapiens | 267,298 |
| E-HCAD-56 | Mouse and human spinal cord | H. sapiens | 245,394 |
| E-GEOD-134144 | Testis development during puberty | H. sapiens | 150,071 |
| E-MTAB-6701 | First trimester fetal-maternal interface | H. sapiens | 135,071 |
| E-CURD-126 | Normal and fibrotic lungs | H. sapiens | 121,080 |
| E-MTAB-9435 | IDHwt glioblastoma tumors | H. sapiens | 62,867 |
| E-GEOD-135922 | Retinal pigment epithelium and choroid | H. sapiens | 55,571 |
| E-MTAB-8381 | Adult human ovaries cortex cells | H. sapiens | 46,428 |
| E-HCAD-10 | Human kidney immune zonation | H. sapiens | 38,813 |
| E-MTAB-10662 | Human fetal lung | H. sapiens | 39,900 |
| E-HCAD-11 | Human colonic mesenchyme in IBD | H. sapiens | 32,899 |
| E-GEOD-114530 | Human fetal kidneys | H. sapiens | 22,148 |
| E-MTAB-9906 | Human fetal intestinal ileum | H. sapiens | 21,097 |
| E-GEOD-124472 | Human embryonic kidney organoid | H. sapiens | 18,079 |
| E-MTAB-8530 | Lung adenocarcinoma circulating tumor cells | H. sapiens | 9,812 |
| E-GEOD-84465 | Glioblastoma infiltrating cells | H. sapiens | 3,588 |
| E-MTAB-9388 | Human gastrulation atlas | H. sapiens | 1,195 |
| E-GEOD-109979 | H9 endoderm differentiation | H. sapiens | 329 |
Section 12: Disease Associations
Mendelian/Monogenic Disease Links
GenCC Gene-Disease Validity
Total associations: 5
| Disease | Classification | Inheritance | Submitter |
|---|
| Inflammatory fibroid polyps (gastrointestinal) | Definitive | AD | G2P |
| Inflammatory fibroid polyps (gastrointestinal) | Strong | AD | Genomics England |
| Inflammatory fibroid polyps (gastrointestinal) | Moderate | AD | Ambry Genetics |
| Gastrointestinal stromal tumor (GIST) | Strong | AD | Labcorp Genetics |
| Isolated cleft palate | Limited | Unknown | Labcorp Genetics |
Orphanet Disease Associations
Total associations: 6
| Orphanet ID | Disease Name | Type |
|---|
| 44890 | Gastrointestinal stromal tumor | Disease |
| 168947 | Myeloid/lymphoid neoplasm with PDGFRA rearrangement | Disease |
| 168940 | Chronic eosinophilic leukemia | Disease |
| 314950 | Primary hypereosinophilic syndrome | Disease |
| 585877 | B-lymphoblastic leukemia/lymphoma with recurrent abnormality | Etiological subtype |
| 199306 | Cleft lip/palate | Morphological anomaly |
Phenotype Associations (HPO)
Total phenotype terms: 55
TOP 50 Associated Phenotypes:
| HPO ID | Phenotype |
|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0003745 | Sporadic |
| HP:0001442 | Typified by somatic mosaicism |
| HP:0100723 | Gastrointestinal stroma tumor |
| HP:0007378 | Neoplasm of the gastrointestinal tract |
| HP:0006753 | Neoplasm of the stomach |
| HP:0100273 | Neoplasm of the colon |
| HP:0100743 | Neoplasm of the rectum |
| HP:0100751 | Esophageal neoplasm |
| HP:0100833 | Neoplasm of the small intestine |
| HP:0100242 | Sarcoma |
| HP:0200008 | Intestinal polyposis |
| HP:0001880 | Increased total eosinophil count |
| HP:0005547 | Myeloproliferative disorder |
| HP:0000175 | Cleft palate |
| HP:0000202 | Orofacial cleft |
| HP:0100334 | Unilateral cleft palate |
| HP:0100337 | Bilateral cleft palate |
| HP:0000220 | Velopharyngeal insufficiency |
| HP:0001611 | Hypernasal speech |
| HP:0009088 | Speech articulation difficulties |
| HP:0010294 | Palate fistula |
| HP:0000327 | Hypoplasia of the maxilla |
| HP:0000689 | Dental malocclusion |
| HP:0006292 | Abnormality of dental eruption |
| HP:0006342 | Peg-shaped maxillary lateral incisors |
| HP:0011044 | Abnormal number of permanent teeth |
| HP:0200153 | Agenesis of lateral incisor |
| HP:0001723 | Restrictive cardiomyopathy |
| HP:0006685 | Endocardial fibrosis |
| HP:0001744 | Splenomegaly |
| HP:0002240 | Hepatomegaly |
| HP:0001392 | Abnormality of the liver |
| HP:0001903 | Anemia |
| HP:0002239 | Gastrointestinal hemorrhage |
| HP:0002576 | Intussusception |
| HP:0005214 | Intestinal obstruction |
| HP:0002015 | Dysphagia |
| HP:0200136 | Oral-pharyngeal dysphagia |
| HP:0002017 | Nausea and vomiting |
| HP:0002019 | Constipation |
| HP:0002033 | Poor suck |
| HP:0008872 | Feeding difficulties in infancy |
| HP:0004395 | Malnutrition |
| HP:0012378 | Fatigue |
| HP:0003326 | Myalgia |
| HP:0000988 | Skin rash |
| HP:0000989 | Pruritus |
| HP:0007400 | Irregular hyperpigmentation |
| HP:0004936 | Venous thrombosis |
GWAS Associations
Total GWAS associations: 34
TOP 30 GWAS Associations:
| Study ID | Trait | Mapped Gene Region | P-value |
|---|
| GCST005993_89 | Mean corpuscular hemoglobin | LINC02283 - LINC02260 | 6.0e-109 |
| GCST006011_105 | Mean corpuscular volume | LINC02283 - LINC02260 | 3.0e-126 |
| GCST005996_35 | Red blood cell count | LINC02283 - LINC02260 | 1.0e-93 |
| GCST007269_46 | Pulse pressure | LNX1 - RPL21P44 | 3.0e-29 |
| GCST000585_9 | Mean corpuscular volume | LINC02283 - LINC02260 | 2.0e-29 |
| GCST000587_5 | Mean corpuscular hemoglobin | LINC02283 - LINC02260 | 3.0e-25 |
| GCST005994_20 | Hematocrit | LINC02283 - LINC02260 | 2.0e-20 |
| GCST008413_2 | Core binding factor AML | GSX2 - RPL22P13; PDGFRA | 3.0e-18 |
| GCST009158_10 | Uterine fibroids | LNX1 | 5.0e-18 |
| GCST000588_1 | Red blood cell count | LINC02283 - LINC02260 | 2.0e-17 |
| GCST005995_8 | Hemoglobin | LINC02283 - LINC02260 | 6.0e-16 |
| GCST009724_93 | Vertical cup-disc ratio | GSX2 - RPL22P13 | 1.0e-15 |
| GCST009724_94 | Vertical cup-disc ratio | RPL22P13 - PDGFRA | 1.0e-14 |
| GCST001803_1 | Corneal curvature | RPL22P13 | 5.0e-14 |
| GCST009723_52 | Vertical cup-disc ratio | PDGFRA | 4.0e-12 |
| GCST004332_4 | Red blood cell count | LINC02283 - LINC02260 | 4.0e-10 |
| GCST006462_49 | Uterine fibroids | GSX2 - RPL22P13 | 9.0e-10 |
| GCST006976_71 | Macular thickness | GSX2 - RPL22P13 | 8.0e-10 |
| GCST001101_2 | Corneal curvature | RPL22P13 - PDGFRA | 1.0e-9 |
| GCST005991_10 | Platelet count | LINC02283 - LINC02260 | 7.0e-9 |
| GCST007267_265 | Systolic blood pressure | LNX1 - RPL21P44 | 2.0e-9 |
| GCST001339_4 | Corneal astigmatism | PDGFRA | 8.0e-9 |
| GCST002502_4 | Corneal curvature | RPL22P13 - PDGFRA | 8.0e-9 |
| GCST005803_1 | Corneal astigmatism | RPL22P13 - PDGFRA | 6.0e-9 |
| GCST008413_3 | Core binding factor AML | GSX2 - RPL22P13; PDGFRA | 6.0e-8 |
| GCST006585_2369 | Blood protein levels | PDGFRA | 1.0e-7 |
| GCST002698_1 | Serum VEGFR2 concentration | LNX1 - RPL21P44 | 5.0e-25 |
| GCST000136_2 | Height | LINC02283 | 4.0e-7 |
| GCST002479_6 | Lupus nephritis in SLE | GSX2 - RPL22P13 | 5.0e-7 |
| ... | ... | ... | ... |
SUMMARY STATISTICS
| Category | Count |
|---|
| Gene Identifiers | |
| Total cross-references | 8,907+ |
| Transcripts | |
| Ensembl transcripts | 23 |
| RefSeq transcripts (human) | 5 |
| CCDS IDs | 1 |
| Exons (canonical) | 23 |
| Protein | |
| UniProt entries | 1 (reviewed) |
| Protein length | 1,089 aa |
| InterPro domains | 15 |
| Structures | |
| PDB structures | 15 |
| AlphaFold model | 1 |
| Variants | |
| ClinVar total | 3,760 |
| Pathogenic | 6 |
| Likely pathogenic | 1 |
| SpliceAI predictions | 4,137 |
| AlphaMissense predictions | 7,179 |
| Pathways & GO | |
| Reactome pathways | 13 |
| GO terms | 70 |
| Interactions | |
| STRING interactions | 4,664+ |
| BioGRID interactions | 432+ |
| ESM2 similar proteins | 151 |
| DIAMOND similar proteins | 98 |
| Regulation | |
| Upstream TF regulators | 26 |
| Drugs | |
| Phase 4 (approved) drugs | 24 |
| Phase 3 drugs | 21 |
| ChEMBL activities | 1,394+ |
| Expression | |
| Tissues expressed | 289 |
| Single-cell datasets | 21 |
| Disease | |
| GenCC associations | 5 |
| Orphanet associations | 6 |
| HPO phenotypes | 55 |
| GWAS associations | 34 |
Document generated using BioBTree integrated biological database system
Reference date: April 2026
I’ve compiled a comprehensive cross-database identifier and functional mapping reference for human PDGFRA (Platelet Derived Growth Factor Receptor Alpha). The document covers all 12 sections with
data from 70+ biological databases:
Key highlights:
- Gene: HGNC:8803 | ENSG00000134853 | Entrez 5156 | OMIM 173490 | Located at chromosome 4q12
- Transcripts: 23 Ensembl transcripts, MANE Select is NM_006206/ENST00000257290 with 23 exons
- Protein: P16234 (UniProt), 1,089 amino acids, receptor tyrosine kinase with 15 InterPro domains
- Structures: 15 PDB structures (mostly X-ray with inhibitor complexes) + AlphaFold model
- Variants: 3,760 ClinVar variants (6 pathogenic, mainly GIST-associated), 4,137 SpliceAI predictions, 7,179 AlphaMissense predictions
- Pathways: 13 Reactome pathways including PDGF signaling and drug resistance pathways
- Drugs: 24 approved drugs (imatinib, sunitinib, avapritinib, etc.) + 21 in Phase 3 trials
- Disease associations: GIST, inflammatory fibroid polyps, myeloid neoplasms with PDGFRA rearrangement, hypereosinophilic syndrome, and cleft palate